Related Experiment Video
Updated: Jul 16, 2026

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
Published on: September 17, 2012
[Mechanism study of antisense cyclin B1 in tumorigenesis inhibition using proteomic technique]
Tao Yang1, Ling Zhang, Fei Yan
1State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, PR. China. ppyangtao@163.com
Background & Objective:
Previous researches showed that down-regulating the expression of cyclin B1 in tumor cells by RNA interference may inhibit tumorigenesis, but the mechanism remains to be clarified. This study was to reveal the molecular mechanism of antisense cyclin B1 in tumorigenesis inhibition by comparative proteomic technique.
Methods:
A recombinant plasmid containing the full-length antisense cDNA of mouse cyclin B1 was transfected into mouse colon carcinoma cell line CT26. Total proteins of transfected cells and control cells were extracted and separated by two-dimensional gel electrophoresis (2-DE). The differential expression proteins were analyzed with PDQuest software, and identified using matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS) and Mascot database searching. The 2 differential proteins with the highest confidence of the peptides were selected and verified by Western blot.
Results:
Seven differentially expressed proteins were identified: Axin2, CCTtheta, DR5, and HPCM27 were up-regulated in transfected cells, while RFP17, mKIAA1195, and LOC77035 were down-regulated. The expression abundance differences of Axin2 and DR5, with the highest confidence, were verified by Western blot.
Conclusions:
Several proteins expressed differentially in CT26 cells after transfection of antisense cyclin B1, which take part in some signal pathways in cell proliferation, differentiation, migration, apoptosis, and transcriptional control. The antitumor effect of antisense cyclin B1 may relate to the interplay of the above proteins.
Insights
Down-regulating cyclin B1 using antisense RNA may inhibit colon cancer by altering proteins involved in cell growth and death. This study identified key protein changes, revealing potential molecular mechanisms for this anti-tumor effect.
Area of Science:
- Molecular Biology
- Proteomics
- Oncology
Context:
- Cyclin B1 plays a crucial role in cell cycle regulation and tumorigenesis.
- Previous studies suggest down-regulating cyclin B1 expression can inhibit tumor growth.
- The precise molecular mechanisms underlying this inhibition require further elucidation.
Purpose:
- To investigate the molecular mechanisms of antisense cyclin B1 in inhibiting tumorigenesis.
- To identify differentially expressed proteins in mouse colon carcinoma CT26 cells following transfection with antisense cyclin B1.
- To elucidate the role of these proteins in cancer development and progression.
Summary:
- Mouse colon carcinoma CT26 cells were transfected with a plasmid expressing antisense cyclin B1.
- Comparative proteomic analysis using 2-DE, MALDI-TOF-MS, and Mascot identified seven differentially expressed proteins.
- Axin2 and DR5 were significantly upregulated, while RFP17, mKIAA1195, and LOC77035 were downregulated, with Axin2 and DR5 expression validated by Western blot.
Impact:
- Identified several proteins (e.g., Axin2, DR5) involved in cell proliferation, differentiation, migration, apoptosis, and transcriptional control.
- Suggests that the antitumor effect of antisense cyclin B1 is mediated by the complex interplay of these differentially expressed proteins.
- Provides a foundation for understanding the molecular basis of antisense cyclin B1 therapy in colon cancer and potentially other malignancies.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
Anaphase Promoting Complex
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
